Literature DB >> 8310509

Histological findings in early routine biopsies of stable renal allograft recipients.

D N Rush1, S F Henry, J R Jeffery, T J Schroeder, J Gough.   

Abstract

Seventy renal allograft biopsies were done in 31 patients, routinely at 1, 2, and 3 months posttransplant, and as clinically indicated, using an automated biopsy "gun." The histological diagnosis was made according to the Banff schema, which emphasizes tubulitis and vascular inflammation over mononuclear cell infiltration. Fifty-three biopsies satisfied histological inclusion criteria. Twenty-nine biopsies were obtained from stable patients, defined as those in whom serum creatinine had changed < 10% in 2 weeks, and in whom immunosuppression (cyclosporine, azathioprine, and prednisone) had not been increased in that interval. Of these biopsies, 30% (9/29) showed rejection, which could not have been predicted from pretransplant (HLA mismatch, panel-reactive antibody titer) or posttransplant (cyclosporine and serum interleukin 2 receptor levels) variables. The significance of these early subclinical rejection episodes is unknown, and their effects on long-term graft histology and function are being examined in a controlled study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8310509     DOI: 10.1097/00007890-199401001-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  Characterization of renal allograft rejection by urinary proteomic analysis.

Authors:  William Clarke; Benjamin C Silverman; Zhen Zhang; Daniel W Chan; Andrew S Klein; Ernesto P Molmenti
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 2.  Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney.

Authors:  Basma Merhi; George Bayliss; Reginald Y Gohh
Journal:  World J Transplant       Date:  2015-12-24

Review 3.  Chronic allograft nephropathy in paediatric renal transplantation.

Authors:  Stephen I Alexander; Jeffrey T Fletcher; Brian Nankivell
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

4.  Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Authors:  R Girlanda; D E Kleiner; Z Duan; E A S Ford; E C Wright; R B Mannon; A D Kirk
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 5.  Application of proteomic analysis to the study of renal diseases.

Authors:  Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

6.  Diagnosis of early acute renal allograft rejection by evaluation of multiple histological features using a Bayesian belief network.

Authors:  J I Kazi; P N Furness; M Nicholson
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

7.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.

Authors:  J Strehlau; M Pavlakis; M Lipman; M Shapiro; L Vasconcellos; W Harmon; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

8.  Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.

Authors:  Mary E Ziegler; Tingchao Chen; James F LeBlanc; Xuelian Wei; David W Gjertson; Ker-Chau Li; Mazdak A Khalighi; Charles R Lassman; Jeffrey L Veale; H Albin Gritsch; Elaine F Reed
Journal:  Transplantation       Date:  2011-08-27       Impact factor: 4.939

Review 9.  Biomarkers for kidney transplant rejection.

Authors:  Denise J Lo; Bruce Kaplan; Allan D Kirk
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

10.  Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.

Authors:  S M Kurian; E Velazquez; R Thompson; T Whisenant; S Rose; N Riley; F Harrison; T Gelbart; J J Friedewald; J Charette; S Brietigam; J Peysakhovich; M R First; M M Abecassis; D R Salomon
Journal:  Am J Transplant       Date:  2017-04-03       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.